AASLD/ILTS Course, Part 4: MASLD and Liver Transplantation (Ticketed)

Description

This course, jointly programmed by AASLD and the International Liver Transplantation Society (ILTS), provides updates on the latest developments in care for patients undergoing liver transplantation. This course will discuss advances in basic, translational and clinical progress in liver transplantation. This timely program explore the most recent data in machine perfusion, transplant oncology and strategies to increase access and equity to help update hepatologists on the contemporary and next stages in liver transplantation.

Journey Maps

Presentations

4:00 PM - 4:05 PM
Nov 15 2024
San Diego, CA

Introduction

Cynthia Tsay, MD, Moderator
Transplant
4:05 PM - 4:25 PM
Nov 15 2024
San Diego, CA

Surgical Options to Treat Obesity/MASLD in the Peri-Transplant Setting

Julie Heimbach, MD, FAASLD, Presenter
Transplant
4:25 PM - 4:45 PM
Nov 15 2024
San Diego, CA

Medical Options to treat Obesity/MASLD in the Peri-Transplant Setting

Manhal J Izzy, MD, Presenter
Transplant
4:45 PM - 5:05 PM
Nov 15 2024
San Diego, CA

ERAS in Obese Transplant Recipients

Ryan Chadha, MD, Presenter
Transplant
5:05 PM - 5:25 PM
Nov 15 2024
San Diego, CA

Pediatric and Youth Obesity: Challenges and Outcomes Post-Transplant

Emily Perito, MD, Presenter
Transplant
5:25 PM - 5:30 PM
Nov 15 2024
San Diego, CA

Q&A

Claire Francoz, MD, PhD, Moderator
Transplant

Objectives

  • Analyze the impact of MASLD on the treatment of patients in need of a liver transplant
Chair

Nazia Selzner, MD, PhD

University of Toronto
Chair

Ryutaro Hirose, MD

University of California, San Francisco
Chair

Pratima Sharma, MD, MS

University of Michigan Medical Center